PhRMA
NOVEMBER 10, 2022
The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.
Drug Topics
NOVEMBER 10, 2022
Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
NOVEMBER 10, 2022
Have you ever noticed that one medicine might be used to treat two, three, seven different conditions? That’s the result of significant additional research and investment, including lengthy and costly clinical trials, biopharmaceutical companies undertake after a medicine is initially approved by the Food and Drug Administration (FDA). Such post approval R&D has changed the course of treatment for many diseases and patient populations.
Drug Topics
NOVEMBER 10, 2022
An over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 10, 2022
The most common cause of death for patients with non-alcoholic fatty liver disease is cardiovascular disease, but it also increases the risk of hepatocellular carcinoma and may surpass hepatitis B and C as the leading cause of this cancer.
Drug Topics
NOVEMBER 10, 2022
For pharmacy owners, understanding tax code can lead to financial benefits at tax time.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 10, 2022
The country is heading into its third Covid winter without crucial tools we’ve relied on at previous points in the pandemic, both as governments roll back their responses and as the virus outruns some of our most important medicine-cabinet defenses. Free at-home tests are no longer showing up at people’s doorsteps. States are reporting outbreak data less frequently, and globally, testing and surveillance programs have been curtailed.
Pharmacy Times
NOVEMBER 10, 2022
Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.
STAT
NOVEMBER 10, 2022
SAN DIEGO — Rayyan Gorashi is keeping her options open. After all, she’s still a second-year bioengineering Ph.D. student at UC San Diego, and there are so many careers to explore. Patent law has been high up on her list ever since a class she took in college. There’s also regulatory affairs. Oh, and science publishing sounds interesting, too.
Pharmacy Times
NOVEMBER 10, 2022
FDA approves brentuximab vedotin for the treatment of patients aged 2 years and older with previously untreated, high-risk classical Hodgkin lymphoma, in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
NOVEMBER 10, 2022
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. aliu. Thu, 11/10/2022 - 09:02.
Pharmacy Times
NOVEMBER 10, 2022
FDA committee voted that trial data do not support the benefits outweighing the risks in patients aged 12 to 17 years and children aged 4 to 11 years for the use of albuterol/budesonide in the treatment of asthma.
Drug Topics
NOVEMBER 10, 2022
Omnipod DASH PDMs are at increased risk of malfunction if overcharged beyond the maximum battery voltage.
Pharmacy Times
NOVEMBER 10, 2022
A physician working in the field of palliative care discusses how pharmacists and physicians can work together to help address issues pertaining to polypharmacy through deprescribing.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
NOVEMBER 10, 2022
Colorado looks set to legalize magic mushrooms in this week’s midterm elections, with the group opposing the ballot question conceding defeat. As of Thursday afternoon, Proposition 122 was passing with 51.4% of the vote, though the referendum is still too close to call officially, with 89% of the vote counted. Colorado would be the second state to legalize psychedelics, following Oregon’s 2020 passage of a similar ballot question.
Pharmacy Times
NOVEMBER 10, 2022
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.
STAT
NOVEMBER 10, 2022
If you want to understand the fickleness of pregnancy and the American laws that regulate it, one place to start would be a gas station in Iowa City, where a 31-year-old sat in the passenger seat of a gray Hyundai, making frantic calls. Her name was Stephanie Dworak, it was September 2021, and she was 20 weeks and five days pregnant. She’d already looked into the abortion clinics in her home state of Nebraska.
Pharmacy Times
NOVEMBER 10, 2022
Study shows there are 2.5 times more breast cancer survivors since the last estimate was conducted in 2007.
The Checkup by Singlecare
NOVEMBER 10, 2022
Could the cure for cystic acne be hiding in plain sight, right on your pantry shelf? The latest TikTok trend might have you believing so. Dozens of videos posted to the social media app recently show users not only extolling the healing powers of honey and garlic for acne, but demonstrating their all-natural beauty routines in detail. . Most of the clips highlight users applying either honey or garlic topically.
Pharmacy Times
NOVEMBER 10, 2022
Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
The Checkup by Singlecare
NOVEMBER 10, 2022
As a pharmacist, you know how busy it gets during the holidays in the pharmacy—and anywhere else for that matter. Patients may be picking up prescriptions while grabbing last-minute decorations, cookware, and gifts during the holidays. Or, they might be stocking up on OTC treatments for typical holiday ailments, such as common cold symptoms, indigestion, or allergies. .
Pharmacy Times
NOVEMBER 10, 2022
One day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.
Fierce Healthcare
NOVEMBER 10, 2022
Telehealth took off during COVID. Here's how companies like Sprinter Health and TytoCare are trying to close the loop on remote care. agliadkovskaya. Thu, 11/10/2022 - 12:33.
European Pharmaceutical Review
NOVEMBER 10, 2022
Minoryx Therapeutics focused on the development of treatments for orphan central nervous system (CNS) disorders and the Neuraxpharm Group announced the completion of a strategic licence agreement. Under the agreement, Minoryx grants Neuraxpharm exclusive European rights to its lead candidate: leriglitazone. Neuraxpharm obtains exclusive rights to commercialise leriglitazone in Europe and will join with Minoryx to continue the further development of leriglitazone.
Fierce Healthcare
NOVEMBER 10, 2022
CMS looking at quality metrics to get ACA exchange plans into value-based care. rking. Thu, 11/10/2022 - 16:00.
Fierce Pharma
NOVEMBER 10, 2022
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster. fkansteiner. Thu, 11/10/2022 - 14:09.
Pharmacy Times
NOVEMBER 10, 2022
The book aims to make the vaccination process less scary and allow more children to be vaccinated.
STAT
NOVEMBER 10, 2022
The World Health Organization defines mental health as a state of mental well-being in which people cope well with the many stresses of life, can realize their own potential, function productively and fruitfully, and contribute to their communities. By that standard, health care workers are in deep trouble. While no group of people or profession is immune to mental health challenges, health care workers face disproportionate stress and burnout , putting them at greater risk of anxiety, depressio
Drug Store News
NOVEMBER 10, 2022
Lannett and HEC will, in exchange for its financial contribution, receive a sub-license to a licensing arrangement between Ypsomed and Sanofi-Aventis Deutschland GmbH.
STAT
NOVEMBER 10, 2022
Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech incubator with global investment giant CBC Group. Sage announced this week that Jonas would leave the company to join a private equity firm. He has been part of the C-suite at Sage Therapeutics since 2013. He helped the company go public, build a pipeline of new antidepressants and other psychiatric medications, and sign a $1.5 billion deal with Biogen.
Fierce Healthcare
NOVEMBER 10, 2022
New research from Twill uncovers how most pregnant Americans struggle with the Invisible Weight of mental health challenges. jpiatt. Thu, 11/10/2022 - 08:55.
PharmaVoice
NOVEMBER 10, 2022
If “winter is coming” in the form of a recession, pharmas can take advantage of an inherent resiliency by crushing these three fundamentals.
STAT
NOVEMBER 10, 2022
Read in English | Leer en inglés. H ARLINGEN, Texas — Aquí en el Valle del Río Grande casi todo el mundo conoce, o cuida, a alguien con demencia. No es ninguna sorpresa. La región presenta algunas de las tasas más altas de la enfermedad en el país. Pero lo que se aprecia menos es la enormidad de la carga que soportan los cuidadores, en su mayoría mexicano-americanos.
Fierce Healthcare
NOVEMBER 10, 2022
HLTH22: Nuance, Nvidia put AI tools in the hands of clinicians, opening pipeline 'from bench to bedside'. aburky. Thu, 11/10/2022 - 14:58.
Expert insights. Personalized for you.
208 
Let's personalize your content